Keck School scientist to co-lead new stroke drug clinical trial
Berislav Zlokovic, MD, PhD, director of the Zilkha Neurogenetic Institute at the Keck School of Medicine of USC, will co-lead a multicenter Phase 2 clinical trial of an experimental drug developed in his lab to treat patients suffering from acute … Read More »